Skip to content Skip to navigation

BioE Lunch & Learn: A COVID-19 Seminar Series

COVID-19 virus on black background

About the COVID-19 Seminar Series

The Stanford Bioengineering department hosted a 5-week speaker series called "BioE Lunch & Learn."  These well-attended talks shared breaking news on how labs are working on ways to prevent, diagnose, and treat the virus, and provided opportunity for Q&A with researchers and learning about getting involved. Thanks to everyone who joined us.

Highlights from the researcher talks 

Watch these short videos featuring highlights from the researcher talks.

Monday, May 11, 2020

“A science writer's perspective on accelerating the impact of bioengineering in society”

Michael Specter, Adjunct Professor, Department of Bioengineering & Staff Writer, The New Yorker

Monday, May 18,  2020

“Inventing our way out of the COVID-19 crisis: roles, responsibilities, and a way forward”

Manu Prakash, Associate Professor of Bioengineering

Intro, Q&A

Pufferfish (a low-cost open source, easily manufactured ventilator)

Project 1000x1000 (N95 factory in a box)

Pneumask (a reusable full-face snorkel mask PPE)

Tuesday, May 26, 2020

“Serological testing for SARS-COV2 antibodies”

Scott Boyd, Associate Professor of Pathology

"Standards development for SARS-COV2 testing"

Marc Salit, Adjunct Professor in Bioengineering

Monday, June 1, 2020

 “Informatics and AI in support of therapy and monitoring of COVID-19”
Russ Altman, The Helix Group

Structure-based drug repurposing for Covid-19" (Stefano Rensi)

Understanding SARS-CoV-2 immune targets to support vaccine design (Binbin Chen)

A networked data science community taming Covid-19 drug literature (Dan Sosa)

AI for automated processing of handwritten Covid-19 case reports (Adam Lavertu)

Evaluation of digital exposure notification technologies for contact tracing (Amit Kaushal)

Monday, June 8, 2020

“Rapid-response ventilation for low-resource settings"

Camarillo Lab (Sam Raymond)

"Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and RNA viruses"

Stanley Qi Lab (Tim Abbott)